Nichols & Pratt Advisers LLP Merck & Co., Inc. Transaction History
Nichols & Pratt Advisers LLP
- $1.44 Billion
- Q2 2025
A detailed history of Nichols & Pratt Advisers LLP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Nichols & Pratt Advisers LLP holds 448,751 shares of MRK stock, worth $35.6 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
448,751
Previous 447,663
0.24%
Holding current value
$35.6 Million
Previous $40.2 Million
11.59%
% of portfolio
2.46%
Previous 2.86%
Shares
33 transactions
Others Institutions Holding MRK
# of Institutions
3,874Shares Held
1.92BCall Options Held
25.7MPut Options Held
24.2M-
Vanguard Group Inc Valley Forge, PA253MShares$20.1 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.5 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.57 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.49 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.74 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $201B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...